Clinical Trial Update: HEM1036 Phase 2 Study in Low Anterior Resection Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for HEM1036 addressing Low Anterior Resection Syndrome (LARS).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Anterior Resection Syndrome

Drugs mentioned

• HEM1036

Snippet

Sponsor: HEM Pharma Inc. | Conditions: LARS - Low Anterior Resection Syndrome | Phase 2 | Status: UNKNOWN